SEC Tracker
Get the app

Possible new GT Biopharma shares

GTBPDilution

Last raise Oct 20, 2026, 424B3: 13.5M shares (29.9% of the 45.1M then)

Known so far: no new shares from the prospectus covers read · shelf room about $2.9M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $2.9M
  • One third of float $2.9M ($8.6M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $2.9M on the S-3 of Mar 6, 2025: the baby-shelf rule (public float under $75M) caps sales at one third of the $8.6M public float stated as of Jun 30, 2025, $2.9M, nothing sold off it in the last 12 months. Sources: S-3 Mar 6, 2025, effective Mar 13, 2025 · public float, as of Jun 30, 2025.

What could become new GT Biopharma (GTBP) shares, from its 10-Q, 10-K, S-1 or 424B filings.

Read so far: the cover share count (45.1M shares, +1168% from 3.6M on Aug 8, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-1 registration filings.

Shares outstanding

45.1M

Nov 2024 to Aug 2026: from 2.2M to 45.1M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.